These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


809 related items for PubMed ID: 9284701

  • 21. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P, Díez JJ, Fernández-Reyes MJ, Méndez J, Bajo MA, Aguilera A, Selgas R.
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
    [Abstract] [Full Text] [Related]

  • 22. Effects of cholinergic modulation on serum insulin-like growth factor-I and its binding proteins in normal and diabetic subjects.
    Ismail IS, Miell JP, Scanlon MF, Peters JR.
    Clin Endocrinol (Oxf); 1995 Feb; 42(2):147-52. PubMed ID: 7535669
    [Abstract] [Full Text] [Related]

  • 23. Free insulin-like growth factor 1 in the vitreous fluid of diabetic patients with proliferative diabetic retinopathy: a case-control study.
    Simó R, Hernández C, Segura RM, García-Arumí J, Sararols L, Burgos R, Cantón A, Mesa J.
    Clin Sci (Lond); 2003 Mar; 104(3):223-30. PubMed ID: 12605576
    [Abstract] [Full Text] [Related]

  • 24. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.
    Jehle PM, Jehle DR, Mohan S, Böhm BO.
    J Endocrinol; 1998 Nov; 159(2):297-306. PubMed ID: 9795371
    [Abstract] [Full Text] [Related]

  • 25. Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes.
    Frystyk J, Skjaerbaek C, Vestbo E, Fisker S, Orskov H.
    Diabetes Metab Res Rev; 1999 Nov; 15(5):314-22. PubMed ID: 10585616
    [Abstract] [Full Text] [Related]

  • 26. Microvascular permeability is increased in both types of diabetes and correlates differentially with serum levels of insulin-like growth factor I (IGF-I) and vascular endothelial growth factor (VEGF).
    Brausewetter F, Jehle PM, Jung MF, Boehm BO, Brueckel J, Hombach V, Osterhues HH.
    Horm Metab Res; 2001 Dec; 33(12):713-20. PubMed ID: 11753756
    [Abstract] [Full Text] [Related]

  • 27. Serum and follicular fluid levels of insulin-like growth factor I (IGF-I), IGF-II, and IGF-binding protein-1 and -3 during the normal menstrual cycle.
    Thierry van Dessel HJ, Chandrasekher Y, Yap OW, Lee PD, Hintz RL, Faessen GH, Braat DD, Fauser BC, Giudice LC.
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1224-31. PubMed ID: 8772603
    [Abstract] [Full Text] [Related]

  • 28. Serum insulin-like growth factor type 1, insulin-like growth factor-binding protein-1, and insulin-like growth factor-binding protein-3 concentrations in patients with thyroid dysfunction.
    Iglesias P, Bayón C, Méndez J, Gancedo PG, Grande C, Diez JJ.
    Thyroid; 2001 Nov; 11(11):1043-8. PubMed ID: 11762714
    [Abstract] [Full Text] [Related]

  • 29. Free and total insulin-like growth factor (IGF)-I, -II, and IGF binding protein-1, -2, and -3 serum levels in patients with active thyroid eye disease.
    Krassas GE, Pontikides N, Kaltsas T, Dumas A, Frystyk J, Chen JW, Flyvbjerg A.
    J Clin Endocrinol Metab; 2003 Jan; 88(1):132-5. PubMed ID: 12519841
    [Abstract] [Full Text] [Related]

  • 30. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects.
    Bang P, Brismar K, Rosenfeld RG, Hall K.
    J Clin Endocrinol Metab; 1994 Apr; 78(4):960-7. PubMed ID: 7512573
    [Abstract] [Full Text] [Related]

  • 31. Residual β-cell function and the insulin-like growth factor system in Danish children and adolescents with type 1 diabetes.
    Sorensen JS, Birkebaek NH, Bjerre M, Pociot F, Kristensen K, Hoejberg AS, Frystyk J, Danish Society for Diabetes in Childhood and Adolescence.
    J Clin Endocrinol Metab; 2015 Mar; 100(3):1053-61. PubMed ID: 25532040
    [Abstract] [Full Text] [Related]

  • 32. Insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBP-1, -2 and -3) in diabetic pregnancy: relationship to macrosomia.
    Yan-Jun L, Tsushima T, Minei S, Sanaka M, Nagashima T, Yanagisawa K, Omori Y.
    Endocr J; 1996 Apr; 43(2):221-31. PubMed ID: 9026269
    [Abstract] [Full Text] [Related]

  • 33. Relationship between non-enzymatic glycosylation and changes in serum insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 levels in patients with type 2 diabetes mellitus.
    Cortizo AM, Lee PD, Cédola NV, Jasper H, Gagliardino JJ.
    Acta Diabetol; 1998 Jul; 35(2):85-90. PubMed ID: 9747960
    [Abstract] [Full Text] [Related]

  • 34. Use of the ligand immunofunctional assay for human insulin-like growth factor ((IGF) binding protein-3 (IGFBP-3) to analyze IGFBP-3 proteolysis and igf-i bioavailability in healthy adults, GH-deficient and acromegalic patients, and diabetics.
    Lassarre C, Duron F, Binoux M.
    J Clin Endocrinol Metab; 2001 May; 86(5):1942-52. PubMed ID: 11344189
    [Abstract] [Full Text] [Related]

  • 35. Association of serum levels of IGF-I and IGFBP-1 with renal function in patients with type 2 diabetes mellitus.
    Akturk M, Arslan M, Altinova A, Ozdemir A, Ersoy R, Yetkin I, Ayvali E, Gonen S, Toruner F.
    Growth Horm IGF Res; 2007 Jun; 17(3):186-93. PubMed ID: 17329141
    [Abstract] [Full Text] [Related]

  • 36. Serum insulin-like growth factor (IGF)-I and IGF-binding protein-1 in elderly people: relationships with cardiovascular risk factors, body composition, size at birth, and childhood growth.
    Kajantie E, Fall CH, Seppälä M, Koistinen R, Dunkel L, Ylihärsilä H, Osmond C, Andersson S, Barker DJ, Forsén T, Holt RI, Phillips DI, Eriksson J.
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1059-65. PubMed ID: 12629086
    [Abstract] [Full Text] [Related]

  • 37. Is growth hormone hypersecretion in diabetic adolescent girls also a daytime problem?
    Halldin MU, Tylleskär K, Hagenäs L, Tuvemo T, Gustafsson J.
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):785-94. PubMed ID: 9713569
    [Abstract] [Full Text] [Related]

  • 38. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.
    Marzullo P, Di Somma C, Pratt KL, Khosravi J, Diamandis A, Lombardi G, Colao A, Rosenfeld RG.
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3001-8. PubMed ID: 11443159
    [Abstract] [Full Text] [Related]

  • 39. Insulin-like growth factors - insulin-like growth factor binding protein axis and diabetic control in insulin-dependent diabetes mellitus.
    Hasegawa T, Hasegawa Y, Takada M, Kurimoto F, Tsuchiya Y.
    Endocr J; 1998 Apr; 45 Suppl():S129-31. PubMed ID: 9790247
    [Abstract] [Full Text] [Related]

  • 40. Short-term suppression of elevated growth hormone concentrations following insulin-like growth factor 1 administration in young adults with type 1 diabetes does not alter glomerular filtration or albumin excretion rates.
    Williams RM, Yuen K, White D, Mallard B, Dalton RN, Acerini CL, Dunger DB.
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):439-45. PubMed ID: 16984235
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 41.